Marlinz Pharma continues expanding its patented Tolcylen® topical product line as it reaches a milestone of 2,500 dispensing healthcare partners. Marlinz Pharma now has 2,500 healthcare dispensing partners, making it much easier for patients to receive clinically proven, economical, in-office-dispensed treatments for many of the most common skin and nail conditions. Patients can often receive targeted therapies without the inconvenience of filling prescriptions, which can have low success rates and be more expensive, even for a co-pay. Marlinz Pharma has several new, exciting products in different stages within our Research and Development pipeline. It will continue investing heavily in new topical treatments and therapies to address common foot-related conditions that have proven hard to treat with current medications.
Marlinz Pharma Reaches a Milestone of 2,500 Physician Partners
